226 related articles for article (PubMed ID: 29079469)
1. Reprogramming energetic metabolism in Alzheimer's disease.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Life Sci; 2018 Jan; 193():141-152. PubMed ID: 29079469
[TBL] [Abstract][Full Text] [Related]
2. Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Neuromolecular Med; 2018 Jun; 20(2):174-204. PubMed ID: 29572723
[TBL] [Abstract][Full Text] [Related]
3. Circadian Rhythms and Energy Metabolism Reprogramming in Parkinson's Disease.
Vallée A; Lecarpentier Y; Vallée JN
Curr Issues Mol Biol; 2019; 31():21-44. PubMed ID: 31160540
[TBL] [Abstract][Full Text] [Related]
4. Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process.
Vallée A; Lecarpentier Y; Vallée JN
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186898
[TBL] [Abstract][Full Text] [Related]
5. Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29659554
[TBL] [Abstract][Full Text] [Related]
6. Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Front Physiol; 2017; 8():352. PubMed ID: 28620312
[TBL] [Abstract][Full Text] [Related]
7. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs.
Vallée A; Lecarpentier Y; Vallée JN
Cells; 2019 Jul; 8(7):. PubMed ID: 31311204
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.
Vallée A; Lecarpentier Y
Front Immunol; 2018; 9():745. PubMed ID: 29706964
[TBL] [Abstract][Full Text] [Related]
10. Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathway.
Lecarpentier Y; Claes V; Vallée A; Hébert JL
Clin Transl Med; 2017 Dec; 6(1):14. PubMed ID: 28405929
[TBL] [Abstract][Full Text] [Related]
11. Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/β-catenin pathway.
Vallée A; Vallée JN; Guillevin R; Lecarpentier Y
Aging (Albany NY); 2020 Feb; 12(3):3095-3113. PubMed ID: 32035419
[TBL] [Abstract][Full Text] [Related]
12. Interplay between the renin-angiotensin system, the canonical WNT/β-catenin pathway and PPARγ in hypertension.
Vallée A; Lévy BL; Blacher J
Curr Hypertens Rep; 2018 Jun; 20(7):62. PubMed ID: 29884931
[TBL] [Abstract][Full Text] [Related]
13. [Aerobic glycolysis activation through canonical WNT/β-catenin pathway in ALS].
Vallée A
Med Sci (Paris); 2018 Apr; 34(4):326-330. PubMed ID: 29658475
[TBL] [Abstract][Full Text] [Related]
14. Metabolic reprogramming in atherosclerosis: Opposed interplay between the canonical WNT/β-catenin pathway and PPARγ.
Vallée A; Vallée JN; Lecarpentier Y
J Mol Cell Cardiol; 2019 Aug; 133():36-46. PubMed ID: 31153873
[TBL] [Abstract][Full Text] [Related]
15. Hypothesis of Opposite Interplay Between the Canonical WNT/beta-catenin Pathway and PPAR Gamma in Primary Central Nervous System Lymphomas.
Vallée A; Lecarpentier Y; Vallée JN
Curr Issues Mol Biol; 2019; 31():1-20. PubMed ID: 30647194
[TBL] [Abstract][Full Text] [Related]
16. Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway.
Vallée A; Lecarpentier Y; Vallée JN
J Exp Clin Cancer Res; 2019 Jul; 38(1):323. PubMed ID: 31331376
[TBL] [Abstract][Full Text] [Related]
17. Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis.
Vallée A; Vallée JN; Guillevin R; Lecarpentier Y
Cell Mol Neurobiol; 2018 May; 38(4):783-795. PubMed ID: 28905149
[TBL] [Abstract][Full Text] [Related]
18. Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease.
Liu L; Wan W; Xia S; Kalionis B; Li Y
Neurochem Int; 2014 Sep; 75():19-25. PubMed ID: 24859746
[TBL] [Abstract][Full Text] [Related]
19. Wnt/β-catenin signaling in Alzheimer's disease.
De Ferrari GV; Avila ME; Medina MA; Perez-Palma E; Bustos BI; Alarcon MA
CNS Neurol Disord Drug Targets; 2014; 13(5):745-54. PubMed ID: 24365184
[TBL] [Abstract][Full Text] [Related]
20. PPARγ agonists: potential treatment for autism spectrum disorder by inhibiting the canonical WNT/β-catenin pathway.
Vallée A; Vallée JN; Lecarpentier Y
Mol Psychiatry; 2019 May; 24(5):643-652. PubMed ID: 30104725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
